Literature DB >> 27822733

[Cutaneous manifestations in renal diseases].

M Schmid-Simbeck1,2, A Udvardi3,4, B Volc-Platzer3,4.   

Abstract

In addition to general skin changes like pallor or dryness and the frequent, often excruciating nephrogenic pruritus, specific diseases in patients with renal failure may occur. Acquired perforating dermatoses are usually also highly pruritic. Calciphylaxis is a severe disease with poor prognosis. Nonhealing wounds with superinfection and progression to sepsis are characteristic. Bullous lesions can be caused by disturbances in porphyrin metabolism. Nephrogenic systemic fibrosis is a disease which was first described in 2000. Its incidence is already on the decline. Furthermore, this article provides an overview of systemic diseases which have both skin symptoms and kidney changes. These include connective tissue diseases, vasculitis or sarcoidosis and amyloidosis. After a kidney transplantation, particular attention must be paid to the development of skin tumors and infections. The last part of this article is dedicated to genodermatoses with skin and renal involvement, where numerous causative mutations have already been characterized. Knowing the correlations of characteristic skin symptoms and specific, potentially life-threatening kidney disease is important in order to initiate further investigations and steps such as referral to nephrologists at an early stage.

Entities:  

Keywords:  Connective tissue diseases; Genodermatoses; Kidney transplantation; Nephrogenic pruritus; Nephrogenic systemic fibrosis

Mesh:

Year:  2016        PMID: 27822733     DOI: 10.1007/s00105-016-3890-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  53 in total

Review 1.  Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature.

Authors:  Madison C Cuffy; Mansher Singh; Richard Formica; Evans Simmons; Ali K Abu Alfa; Kacie Carlson; Michael Girardi; Shawn E Cowper; Sanjay Kulkarni
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

2.  Low-dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipients.

Authors:  G E Gibson; A O'Grady; E W Kay; G M Murphy
Journal:  J Eur Acad Dermatol Venereol       Date:  1998-01       Impact factor: 6.166

3.  Positive effect of low-dose imatinib mesylate in a patient with nephrogenic systemic fibrosis.

Authors:  Tina Rask Elmholdt; Michael Pedersen; Bettina Jørgensen; Mette Ramsing; Anne Braae Olesen
Journal:  Acta Derm Venereol       Date:  2011-06       Impact factor: 4.437

4.  Aggressive squamous cell carcinomas in organ transplant recipients.

Authors:  S Euvrard; J Kanitakis; C Pouteil-Noble; F Disant; G Dureau; J Finaz de Villaine; A Claudy; J Thivolet
Journal:  Transplant Proc       Date:  1995-04       Impact factor: 1.066

5.  Topical capsaicin therapy for uremic pruritus in patients on hemodialysis.

Authors:  Atieh Makhlough; Shahram Ala; Zohreh Haj-Heydari; Zahra Kashi; Alireza Bari
Journal:  Iran J Kidney Dis       Date:  2010-04       Impact factor: 0.892

6.  Randomised crossover trial of naltrexone in uraemic pruritus.

Authors:  G Peer; S Kivity; O Agami; E Fireman; D Silverberg; M Blum; A laina
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321

7.  Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial.

Authors:  Ali Ihsan Gunal; Goksel Ozalp; Tahir Kurtulus Yoldas; Servin Yesil Gunal; Ercan Kirciman; Huseyin Celiker
Journal:  Nephrol Dial Transplant       Date:  2004-12       Impact factor: 5.992

8.  Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease.

Authors:  Joanna Suseł; Aleksandra Batycka-Baran; Adam Reich; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2014-05       Impact factor: 4.437

Review 9.  The role of gabapentin in treating diseases with cutaneous manifestations and pain.

Authors:  Noah Scheinfeld
Journal:  Int J Dermatol       Date:  2003-06       Impact factor: 2.736

10.  Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.

Authors:  Aurang Z Khawaja; Deirdre B Cassidy; Julien Al Shakarchi; Damian G McGrogan; Nicholas G Inston; Robert G Jones
Journal:  Insights Imaging       Date:  2015-08-08
View more
  1 in total

1.  Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis.

Authors:  Philipp Russ; Martin Russwurm; Birgit Kortus-Goetze; Joachim Hoyer; Sahana Kamalanabhaiah
Journal:  BMC Nephrol       Date:  2019-04-02       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.